Skip to main content

Table 2 Drugs that contraindicate initiation of fingolimod

From: Analysis of cardiac monitoring and safety data in patients initiating fingolimod treatment in the home or in clinic

Contraindicate initiation of fingolimod in all settings

Contraindicate initiation of fingolimod in patient’s home but not in a medical facility

Class Ia or class III antiarrhythmic drugs

Drugs that lower heart rate

Drugs that prolong QT interval with risk of torsades de pointes

Amiodarone

Calcium-channel blockers:

Anagrelide

Dofetilide

 Diltiazem

Arsenic trioxide

Disopyramide

 Verapamil

Azithromycin

Dronedarone

Cardioselective β-blockers:

Chloroquine

Ibutilide

 Acebutolol

Chlorpromazine

Procainamide

 Atenolol

Ciprofloxacin

Quinidine

 Betaxolol

Citalopram

Sotalol

 Bisoprolol

Cilostazol

 Esmolol

Clarithromycin

 Metoprolol

Cocaine

 Nebivolol

Donepezil

β-Blockers with intrinsic sympathomimetic activity:

Droperidol

 Acebutolol

Erythromycin

 Carteolol

Escitalopram

 Penbutolol

Flecainide

 Pindolol

Fluconazole

α-/β-Blockers:

Halofantrine

 Carvedilol

Haloperidol

 Labetalol

Levofloxacin

Nonselective β-blockers:

Methadone

 Levobunolol

Moxifloxacin

 Metipranolol

Ondansetron

 Nadolol

Oxaliplatin

 Propranolol

Papaverine hydrochloride

 Sotalol

Pentamidine

 Timolol

Pimozide

Other:

Propofol

 Adenosine

Sevoflurane

 Clonidine

Thioridazine

 Digoxin

Vandetanib

 Donepezil

 

 Ivabradine